Quality & Compliance

Are you compliant with the new guidelines for elemental impurities? There’s only six months left to get up to speed.

If pharma wants to adopt continuous manufacturing, it must employ control procedures to ensure quality.

How important is pharmacovigilance in the post-market safety of drugs?

Real-time monitoring and analysis of biologics during manufacturing is within reach

We forge ahead to celebrate the fantastic individuals involved in bettering the pharma industry.

India has held pharma’s interest for decades, but it is a challening market to work in.

Six Sigma has the potential to deliver real cost savings by improving productivity and reducing defects, but making the change is challenging.

Mark Paxton was appointed CEO of Rx-360 in 2015. Here, he discusses the journey so far

Martin Van Trieste tells the emotional story behind the creation of Rx-360

What separates a good model from a bad model in bioprocess development?